183 related articles for article (PubMed ID: 24192157)
1. Diffuse pontine lesions in children with neurofibromatosis type 1: making a case for unidentified bright objects.
Hervey-Jumper SL; Singla N; Gebarski SS; Robertson P; Maher CO
Pediatr Neurosurg; 2013; 49(1):55-9. PubMed ID: 24192157
[TBL] [Abstract][Full Text] [Related]
2. Brain stem involvement in children with neurofibromatosis type 1: role of magnetic resonance imaging and spectroscopy in the distinction from diffuse pontine glioma.
Broniscer A; Gajjar A; Bhargava R; Langston JW; Heideman R; Jones D; Kun LE; Taylor J
Neurosurgery; 1997 Feb; 40(2):331-7; discussion 337-8. PubMed ID: 9007866
[TBL] [Abstract][Full Text] [Related]
3. Unidentified bright objects in neurofibromatosis type 1: conventional MRI in the follow-up and correlation of microstructural lesions on diffusion tensor images.
Ferraz-Filho JR; José da Rocha A; Muniz MP; Souza AS; Goloni-Bertollo EM; Pavarino-Bertelli EC
Eur J Paediatr Neurol; 2012 Jan; 16(1):42-7. PubMed ID: 22088602
[TBL] [Abstract][Full Text] [Related]
4. Thalamo-striatal T2-weighted hyperintensities (unidentified bright objects) correlate with cognitive impairments in neurofibromatosis type 1 during childhood.
Chabernaud C; Sirinelli D; Barbier C; Cottier JP; Sembely C; Giraudeau B; Deseille-Turlotte G; Lorette G; Barthez MA; Castelnau P
Dev Neuropsychol; 2009; 34(6):736-48. PubMed ID: 20183730
[TBL] [Abstract][Full Text] [Related]
5. Spontaneous remission of a diffuse brainstem lesion in a neonate.
Schomerus L; Merkenschlager A; Kahn T; Hirsch W
Pediatr Radiol; 2007 Apr; 37(4):399-402. PubMed ID: 17318651
[TBL] [Abstract][Full Text] [Related]
6. [Corpus callosum tumor as the presenting symptom of neurofibromatosis type 1 in a patient and literature review].
Pascual-Castroviejo I; Pascual-Pascual SI; Velazquez-Fragua R; Viaño J
Rev Neurol; 2012 Nov; 55(9):528-32. PubMed ID: 23111991
[TBL] [Abstract][Full Text] [Related]
7. Using a semi-automated approach to quantify Unidentified Bright Objects in Neurofibromatosis type 1 and linkages to cognitive and academic outcomes.
Harriott EM; Nguyen TQ; Landman BA; Barquero LA; Cutting LE
Magn Reson Imaging; 2023 May; 98():17-25. PubMed ID: 36608909
[TBL] [Abstract][Full Text] [Related]
8. Characterizing the microstructural basis of "unidentified bright objects" in neurofibromatosis type 1: A combined in vivo multicomponent T2 relaxation and multi-shell diffusion MRI analysis.
Billiet T; Mädler B; D'Arco F; Peeters R; Deprez S; Plasschaert E; Leemans A; Zhang H; den Bergh BV; Vandenbulcke M; Legius E; Sunaert S; Emsell L
Neuroimage Clin; 2014; 4():649-58. PubMed ID: 24936416
[TBL] [Abstract][Full Text] [Related]
9. Use of "unidentified bright objects" on MRI for diagnosis of neurofibromatosis 1 in children.
DeBella K; Poskitt K; Szudek J; Friedman JM
Neurology; 2000 Apr; 54(8):1646-51. PubMed ID: 10762507
[TBL] [Abstract][Full Text] [Related]
10. Serial MR imaging and 1H-MR spectroscopy of unidentified bright objects in a case of neurofibromatosis type 1.
Imamura A; Matsuo N; Okuda M; Morita H; Iwata M; Yamazaki Y; Takahashi Y
Brain Dev; 2005 Dec; 27(8):595-7. PubMed ID: 15878248
[TBL] [Abstract][Full Text] [Related]
11. Relationship between T2-weighted hyperintensities (unidentified bright objects) and lower IQs in children with neurofibromatosis-1.
Denckla MB; Hofman K; Mazzocco MM; Melhem E; Reiss AL; Bryan RN; Harris EL; Lee J; Cox CS; Schuerholz LJ
Am J Med Genet; 1996 Feb; 67(1):98-102. PubMed ID: 8678124
[TBL] [Abstract][Full Text] [Related]
12. Interpretation of magnetic resonance images in diffuse intrinsic pontine glioma: a survey of pediatric neurosurgeons.
Hankinson TC; Campagna EJ; Foreman NK; Handler MH
J Neurosurg Pediatr; 2011 Jul; 8(1):97-102. PubMed ID: 21721895
[TBL] [Abstract][Full Text] [Related]
13. Neuropsychological profile in Italian children with neurofibromatosis type 1 (NF1) and their relationships with neuroradiological data: Preliminary results.
Parmeggiani A; Boiani F; Capponi S; Duca M; Angotti M; Pignataro V; Sacrato L; Spinardi L; Vara G; Maltoni L; Cecconi I; Pastore Trossello M; Franzoni E
Eur J Paediatr Neurol; 2018 Sep; 22(5):822-830. PubMed ID: 29802023
[TBL] [Abstract][Full Text] [Related]
14. Three-dimensional anisotropy contrast imaging of pontine gliomas: 2 case reports.
Kashimura H; Inoue T; Ogasawara K; Beppu T; Kanbara Y; Ogawa A
Surg Neurol; 2007 Feb; 67(2):156-9; discussion 159. PubMed ID: 17254873
[TBL] [Abstract][Full Text] [Related]
15. Brain apparent diffusion coefficient evaluation in pediatric patients with neurofibromatosis type 1.
Tognini G; Ferrozzi F; Garlaschi G; Piazza P; Patti A; Virdis R; Bertolino C; Bertolino G; Manfredini D; Zompatori M; Crisi G
J Comput Assist Tomogr; 2005; 29(3):298-304. PubMed ID: 15891494
[TBL] [Abstract][Full Text] [Related]
16. Measuring the pons: a non-invasive biomarker for pediatric diffuse intrinsic pontine glioma.
Warren KE
CNS Oncol; 2014 May; 3(3):181-3. PubMed ID: 25055124
[No Abstract] [Full Text] [Related]
17. Neurofibromatosis type 1: diffusion weighted imaging findings of brain.
Alkan A; Sigirci A; Kutlu R; Ozcan H; Erdem G; Aslan M; Ates O; Yakinci C; Egri M
Eur J Radiol; 2005 Nov; 56(2):229-34. PubMed ID: 15963674
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and therapeutic challenges owing to concurrent pontine glioma and acute lymphoblastic leukemia.
Anoop P; Hargrave D; Zacharoulis S; Saran F
J Pediatr Hematol Oncol; 2008 Jun; 30(6):454-7. PubMed ID: 18525463
[TBL] [Abstract][Full Text] [Related]
19. Brainstem tumors in patients with neurofibromatosis type 1: a distinct clinical entity.
Molloy PT; Bilaniuk LT; Vaughan SN; Needle MN; Liu GT; Zackai EH; Phillips PC
Neurology; 1995 Oct; 45(10):1897-902. PubMed ID: 7477989
[TBL] [Abstract][Full Text] [Related]
20. Unidentified bright objects on brain MRI in children as a diagnostic criterion for neurofibromatosis type 1.
Lopes Ferraz Filho JR; Munis MP; Soares Souza A; Sanches RA; Goloni-Bertollo EM; Pavarino-Bertelli EC
Pediatr Radiol; 2008 Mar; 38(3):305-10. PubMed ID: 18231788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
